Journal Article
Prescription Drug Advertising and Drug Utilization: The Role of Medicare Part D
March 18, 2023
Featured Experts: Darius Lakdawalla, PhD, Neeraj Sood, PhD
Research
All Research Featured Research
Journal Article
Reforming the Medicare Part D Benefit Design: Financial Implications for Beneficiaries, Private Plans, Drug Manufacturers, and the Federal Government
July 14, 2022
Featured Experts: Erin Trish, PhD, Geoffrey Joyce, PhD
Journal Article
Pharmacy Switching in Response to Preferred Pharmacy Networks in Medicare Part D
March 17, 2022
Featured Experts: Erin Trish, PhD, Geoffrey Joyce, PhD
Journal Article
Substance Use Disorders Among Older Populations: What Role Do Race and Ethnicity Play in Treatment and Completion?
January 1, 2022
Featured Experts: Alberto Ortega, PhD
Perspective
Money for the Infrastructure Bill is Coming at the Expense of Medicare Part D
September 16, 2021
Featured Experts: Erin Trish, PhD, Dana Goldman, PhD
Journal Article
Comparison of Spending on Common Generic Drugs by Medicare vs Costco Members
July 7, 2021
Featured Experts: Erin Trish, PhD, Karen Van Nuys, PhD, Geoffrey Joyce, PhD
News
Monthly Cost Sharing Doubles Throughout the Year for Some Medicare Insulin Users
February 9, 2021
Featured Experts: Erin Trish, PhD, Geoffrey Joyce, PhD
Journal Article
Variation in Generic Dispensing Rates in Medicare Part D
November 13, 2020
Featured Experts: Geoffrey Joyce, PhD
Perspective
Sharing Drug Rebates With Medicare Part D Patients: Why And How
September 15, 2020
Featured Experts: Steven M. Lieberman, MPhil, MA, Paul Ginsburg, PhD, Erin Trish, PhD
News
Drug Cost-Sharing Based on Net Price Benefits Medicare Part D Patients
March 17, 2020
Featured Experts: Erin Trish, PhD, Geoffrey Joyce, PhD
White Paper
How Would Sharing Rebates at the Point-Of-Sale Affect Beneficiary Cost-Sharing in Medicare Part D?
March 17, 2020
Featured Experts: Erin Trish, PhD, Geoffrey Joyce, PhD
Perspective
Who Pays in Medicare Part D? Giving Plans More Skin in the Game
November 20, 2019
Featured Experts: Erin Trish, PhD, Paul Ginsburg, PhD, Geoffrey Joyce, PhD, Dana Goldman, PhD
Perspective
Ending Drug Rebates will Increase Medicare Part D Premiums, but Most Seniors will be Insulated From It
February 21, 2019
Featured Experts: Erin Trish, PhD, Dana Goldman, PhD
Perspective
Ending Drug Rebates Will Increase Medicare Part D Premiums. Most Seniors Will Be Insulated From It
February 21, 2019
Featured Experts: Erin Trish, PhD, Dana Goldman, PhD
Perspective
Trump Might Actually Lower Drug Prices
August 29, 2018
Featured Experts: Dana Goldman, PhD
Perspective
Medicare’s ‘Catastrophic Insurance’ Can Be a Catastrophe for Middle-Income Seniors
July 23, 2018
Featured Experts: Erin Trish, PhD, Geoffrey Joyce, PhD
Journal Article
Growing Number of Unsubsidized Part D Beneficiaries with Catastrophic Spending Suggests Need for Out-Of-Pocket Cap
July 10, 2018
Featured Experts: Erin Trish, PhD, Geoffrey Joyce, PhD
News
Without a Cap, Out-of-Pocket Drug Spending Poses Great Risk
July 10, 2018
Featured Experts: Erin Trish, PhD, Geoffrey Joyce, PhD
- ← Previous
- 1
- 2
- 3
- 4
- Next →